SIC 2835 – In Vitro and In Vivo Diagnostic Substances
Valuation | |
---|---|
Market Cap ($M) | 86.94 |
Enterprise Value ($M) | 78.31 |
Book Value ($M) | -12.27 |
Book Value / Share | -0.43 |
Price / Book | -7.08 |
NCAV ($M) | -35.60 |
NCAV / Share | -1.24 |
Price / NCAV | -2.44 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | n/a |
Return on Assets (ROA) | -0.81 |
Return on Equity (ROE) | -2.37 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.56 |
Current Ratio | 1.62 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 11.76 |
Assets | 35.08 |
Liabilities | 47.35 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 1.88 |
Operating Income | -23.25 |
Net Income | -60.66 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -20.71 |
Cash from Investing | -0.51 |
Cash from Financing | 20.43 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Bio-rad Laboratories, Inc. | 9.70 | 82.94 | |
13G/A | AWM Investment Company, Inc. | 7.50 | 73.18 | |
13D/A | Broadwood Partners, L.p. | 40.20 | 127.60 | |
13G/A | Smith Patrick W | 10.50 | ||
13G | Pura Vida Investments, Llc | 4.57 | -12.93 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
1,881 | 18,516 | 10.16 | |
14,419 | 81,772 | 17.63 | |
2,650 | 29,697 | 8.92 | |
(click for more detail) |
Similar Companies | |
---|---|
NVCT – Nuvectis Pharma, Inc. | OCEA – Ocean Biomedical, Inc. |
OCGN – Ocugen, Inc. | OKYO – OKYO Pharma Limited |
ONCO – Onconetix, Inc. |
Financial data and stock pages provided by
Fintel.io